Best treatment option for infantile chronic myeloid leukemia patients: imatinib or hematopoietic stem cell transplantation?

Pediatr Transplant. 2014 May;18(3):316-7. doi: 10.1111/petr.12234. Epub 2014 Feb 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzamides / therapeutic use*
  • Fatal Outcome
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Imatinib Mesylate
  • Infant
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate